Sitrodin 150IU Injection

Sitrodin 150IU Injection contains the active substance Urofollitropin. It is an ovulation stimulator belonging to the group of medications called gonadotropins. It is used to treat infertility in women who are not ovulating, including those with polycystic ovarian disease, and who have not responded to treatment with clomiphene citrate. It is also used to promote the development of multiple follicles and therefore enhance fertility in women undergoing IVF (in-vitro fertilisation) or other assisted conception methods. It is also indicated to treat infertility in men due to low sperm count.

Do not take Sitrodin 150IU Injection if you are allergic to Urofollitropin or any other ingredient of this medicine. Do not take this medicine if you have a tumour of the pituitary gland (a gland located at the base of the brain which produces certain hormones, including growth hormones) or of the hypothalamus (an area located beneath the thalamus which controls the conditions within your body including body temperature and blood pressure) or of the uterus, ovaries, breast, testicles, or prostate gland.

Before initiating treatment, you will be evaluated for underactive thyroid, hormone levels, and tumours of the pituitary and hypothalamus. Do not take Sitrodin 150IU Injection if you have ovarian cysts that are not due to polycystic ovarian disease, vaginal bleeding, early menopause, structural problems in the reproductive organs, if your uterus has been removed, or if you are pregnant or breastfeeding.

Inform your physician immediately if you experience abdominal pain and swelling, weight gain, diarrhoea, difficulty in breathing, or decreased urination. Inform your physician if you have liver problems or a history of blood clotting disease before starting treatment with Sitrodin 150IU Injection.

Sitrodin 150IU Injection is used in the treatment of the following: Infertility in women

In the absence of sufficient endogenous luteinising hormone (LH), Sitrodin 150IU Injection bind to the follicle-stimulating hormone receptor (FSH), resulting in ovulation. It also attaches to the LH receptor, causing appropriate hormone release and treating infertility in women.

Sitrodin 150IU Injection will be given to you by a doctor or nurse in a hospital or clinic setting. It is given as an intramuscular injection (into your muscles) or under the skin. Do not self-administer the injection. Your doctor will decide the dose, route of administration and duration of the treatment based on your disease severity, body weight, and other factors.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious side effects of Sitrodin 150IU Injection are: Severe allergic reactions (hypersensitivity reactions) Common side effects of Sitrodin 150IU Injection are: Abdominal pain or swelling Headache Nausea Pelvic pain Overstimulation of ovaries Pain or inflammation at the injection site Mood swings

If you have missed any dosing appointments, inform your doctor and schedule immediately. Sitrodin 150IU Injection can increase your risk of ectopic pregnancy (pregnancy outside of the womb) if you have a history of fallopian tube disease, miscarriage, multiple pregnancies (twins and triplets), and birth defects in the baby. Your doctor will regularly perform ultrasound scans and blood tests to monitor your response to the treatment.